Premium
Assessment of donor cell and matrix survival in fresh articular cartilage allografts in a goat model
Author(s) -
Jackson Douglas W.,
Halbrecht Jeffery,
Proctor Christopher,
van Sickle David,
Simon Timothy M.
Publication year - 1996
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.1100140214
Subject(s) - transplantation , cartilage , articular cartilage , articular cartilage repair , meniscus , dna , pathology , matrix (chemical analysis) , medicine , surgery , anatomy , biology , chemistry , osteoarthritis , genetics , physics , alternative medicine , incidence (geometry) , chromatography , optics
The long‐term survival of allografts of articular cartilage has been proposed to be dependent on the survival of the cells that maintain the unique structural and material properties of the allograft. In this study, we assessed cell survival in 24 fresh articular cartilage allografts of the medial plateau in a Spanish‐goat model. A DNA‐probe technique was used to distinguish clearly between DNA from donor (allograft) and host cells. The intraarticular survival of viable allograft chondrocytes in the transplanted articular cartilage started to diminish as early as 3 weeks after transplantation; however, there was considerable variation in the amount of donor cell DNA detected in the allografts at 6 and 12 months following transplantation. This contrasts with our experience with fresh allografts of ligament, tendon, and meniscus, in which no donor DNA was detected 4 weeks after transplantation. DNA from host cells was present in all articular cartilage allografts, as evidenced by detectable unique host DNA patterns. Histological and histochemical assays showed that none of the transplants demonstrated normal structure and composition at 1 year after transplantation. The grafts in which large quantities of donor DNA were present appeared grossly superior to those with no or reduced remaining demonstrable donor DNA.